Literature DB >> 17573715

Role of the highly structured 5'-end region of MDR1 mRNA in P-glycoprotein expression.

Rebecca A Randle1, Selina Raguz, Christopher F Higgins, Ernesto Yagüe.   

Abstract

Overexpression of P-glycoprotein, encoded by the MDR1 (multidrug resistance 1) gene, is often responsible for multidrug resistance in acute myeloid leukaemia. We have shown previously that MDR1 (P-glycoprotein) mRNA levels in K562 leukaemic cells exposed to cytotoxic drugs are up-regulated but P-glycoprotein expression is translationally blocked. In the present study we show that cytotoxic drugs down-regulate the Akt signalling pathway, leading to hypophosphorylation of the translational repressor 4E-BP [eIF (eukaryotic initiation factor) 4E-binding protein] and decreased eIF4E availability. The 5'-end of MDR1 mRNA adopts a highly-structured fold. Fusion of this structured 5'-region upstream of a reporter gene impeded its efficient translation, specifically under cytotoxic stress, by reducing its competitive ability for the translational machinery. The effect of cytotoxic stress could be mimicked in vivo by blocking the phosphorylation of 4E-BP by mTOR (mammalian target of rapamycin) using rapamycin or eIF4E siRNA (small interfering RNA), and relieved by overexpression of either eIF4E or constitutively-active Akt. Upon drug exposure MDR1 mRNA was up-regulated, apparently stochastically, in a small proportion of cells. Only in these cells could MDR1 mRNA compete successfully for the reduced amounts of eIF4E and translate P-glycoprotein. Consequent drug efflux and restoration of eIF4E availability results in a feed-forward relief from stress-induced translational repression and to the acquisition of drug resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17573715      PMCID: PMC2049040          DOI: 10.1042/BJ20070235

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1.

Authors:  Z Hu; S Jin; K W Scotto
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

Review 2.  Translational regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins.

Authors:  M J Clemens
Journal:  J Cell Mol Med       Date:  2001 Jul-Sep       Impact factor: 5.310

Review 3.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 4.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

5.  Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs.

Authors:  Emma K Baker; Ricky W Johnstone; John R Zalcberg; Assam El-Osta
Journal:  Oncogene       Date:  2005-12-01       Impact factor: 9.867

Review 6.  Mechanisms of cancer drug resistance.

Authors:  Michael M Gottesman
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

7.  Secondary structure of the 5'-region of PGY1/MDR1 mRNA.

Authors:  E V Kostenko; R S Beabealashvilly; V V Vlassov; M A Zenkova
Journal:  FEBS Lett       Date:  2000-06-23       Impact factor: 4.124

Review 8.  Activation of the PI3K/Akt pathway and chemotherapeutic resistance.

Authors:  Kip A West; S Sianna Castillo; Phillip A Dennis
Journal:  Drug Resist Updat       Date:  2002-12       Impact factor: 18.500

9.  P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation.

Authors:  Ernesto Yague; Angel L Armesilla; Georgina Harrison; James Elliott; Alessandro Sardini; Christopher F Higgins; Selina Raguz
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

Review 10.  Pushing the limits of the scanning mechanism for initiation of translation.

Authors:  Marilyn Kozak
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

View more
  4 in total

1.  Inhibition of mTOR Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy.

Authors:  Xiaosa Chi; Cheng Huang; Rui Li; Wei Wang; Mengqian Wu; Jinmei Li; Dong Zhou
Journal:  J Mol Neurosci       Date:  2017-02-22       Impact factor: 3.444

Review 2.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

3.  MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.

Authors:  Heounjeong Go; Ji-Young Jang; Pil-Jong Kim; Young-Goo Kim; Soo Jeong Nam; Jin Ho Paik; Tae Min Kim; Dae Seog Heo; Chul-Woo Kim; Yoon Kyung Jeon
Journal:  Oncotarget       Date:  2015-06-20

4.  Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells.

Authors:  Mark Borris Docdoc Aldonza; Ji-Young Hong; Song Yi Bae; Jayoung Song; Won Kyung Kim; Jedo Oh; Yoonho Shin; Seung Ho Lee; Sang Kook Lee
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.